Literature DB >> 21994201

Mixed medullary-follicular carcinoma of the thyroid: diagnostic dilemmas in fine-needle aspiration cytology.

Atef N Hanna1, Claire W Michael, Xin Jing.   

Abstract

Mixed medullary-follicular carcinoma (MMFC) of thyroid is an extremely rare tumor, characterized by coexistence of morphological and immunohistochemical features of both medullary carcinoma and follicular (or papillary) carcinoma. We herein present fine needle aspiration (FNA) findings of a histology-confirmed MMFC along with a review of literature. The patient was a 64-year-old woman who had a history of Hashimoto's thyroiditis and presented with enlargement of preexisting right thyroid nodule. An US-guided FNA of the thyroid nodule was performed and conventional smears were prepared. A cytologic diagnosis of "positive for malignancy, consistent with medullary thyroid carcinoma (MTC)" was rendered based on the presence of features characteristic for MTC, and the absence of components of follicular neoplasm (adenoma and carcinoma) or papillary carcinoma. However, microscopic examination of the follow-up total thyroidectomy specimen with the aid of immunocytochemical study detected minor portion of follicular carcinoma in addition to MTC. A histologic diagnosis of MMFC was then established. While specific identification of MMFC by FNA may be difficult, it should be emphasized that adequate sampling in conjunction with the proper immunostaining panel could have highlighted the different aspects of the mixed tumor.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21994201     DOI: 10.1002/dc.21560

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  True mixed medullary papillary carcinoma of the thyroid: a case report with low blood calcitonin levels.

Authors:  Pablo Zoroquiain; Javiera Torres; Ignacio Goñi; Lizzet Fernández; Antonieta Solar
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

Review 2.  Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.

Authors:  Stefano La Rosa; Fausto Sessa; Silvia Uccella
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

3.  F-18 FDG-PET-CT in the Diagnostic of a Late Medullary Thyroid Carcinoma Recurrence in a Patient with Follicular-Papillary Thyroid Cancer.

Authors:  Doina Piciu; Andra Piciu
Journal:  Case Rep Endocrinol       Date:  2014-02-20

4.  Mixed subtype thyroid cancer: A surveillance, epidemiology, and end results database analysis.

Authors:  Chunping Liu; Qiuyang Zhao; Zhi Li; Shuntao Wang; Yiquan Xiong; Zeming Liu; Tao Huang
Journal:  Oncotarget       Date:  2017-09-23

5.  Plasma miR-323 as a Biomarker for Screening Papillary Thyroid Cancer From Healthy Controls.

Authors:  Yang Liu; Lin Li; Zheng Liu; Qingling Yuan; Xiubo Lu
Journal:  Front Med (Lausanne)       Date:  2020-05-15

6.  Mixed medullary-papillary thyroid carcinoma with mixed lymph node metastases: A case report.

Authors:  Vanessa Guerreiro; Cláudia Costa; Joana Oliveira; Ana Paula Santos; Mónica Farinha; Manuel Jácome; Paula Freitas; Davide Carvalho; Isabel Torres
Journal:  Clin Case Rep       Date:  2021-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.